Pharmaceutical Recalls

​The following drugs have been recalled. Please follow the links shown in the details of the recall below in order to get more information.

 


March 29, 2018

Bayer is voluntarily recalling Alka-Seltzer Plus® packages that:
  • Were sold only in the U.S. at Walmart, CVS, Walgreens and Kroger (including Dillons Food Stores, Fred Meyer, Fry’s Food Stores, Ralphs, King Soopers and Smith’s Food and Drug) after February 9, 2018.
  • Can be identified by checking the Bayer logo located on the lower left corner of the front of the carton. If the logo has an orange or green background, the product is included in the recall .
The affected packages are being recalled because the ingredients on the front sticker may not match the actual product in the carton.  The Alka-Seltzer Plus products subject to the recall are intended to temporarily relieve symptoms associated with cold and flu, such as cough, congestion, fever and/or mucus.  There may be potential for serious health consequences. 

January 10, 2018

Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall - Product Mislabeling

Click Here for FDA Webpage


December 5, 2017

Ph​armacist Choice Alcohol Prep Pads by Simple Diagnostics: Recall - Lack of Sterility Assurance and Other Quality Issues

December 4, 2017 : Recommended Voluntary Recall

The U.S. Food and Drug Administration has recommended that Primus Pharmaceuticals, Scottsdale, Arizona, voluntarily recall Limbrel, a capsule marketed to “manage the metabolic processes associated with osteoarthritis.” The company has not yet acted to remove the product from the market. Although the product is marketed as a medical food, the preliminary determination of the FDA investigation is that Limbrel is an unapproved new drug. The agency does not have mandatory recall authority over drug products.
 
The FDA reminds consumers not to use Limbrel because of the risk of drug-induced liver injury, and a lung condition called hypersensitivity pneumonitis. Consumers taking this product should stop immediately and contact their health care provider. Health care providers who are aware that their patients are taking Limbrel should advise them to stop using it.

 

November 30, 2017

Greenstone LLC, a wholly owned subsidiary of Pfizer Inc., is  voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone initiated this recall because product from these lots has the potential to be super potent or sub potent. Products were distributed nationwide to wholesalers/retailers from November 2016 through June 2017 in the United States.
NDC Lot Number Expiration Date Strength Configuration/Count
59762-1061-1 R83962 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 R93347 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 R93348 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 R93349 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 R93350 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 R93351 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 R93352 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 S57831 2021 NOV 30 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 S57832 2021 NOV 30 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-1 S57834 2021 NOV 30 2.5 mg/0.025 mg Bottle containing 100 tablets
59762-1061-2 R93356 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 1000 tablets
59762-1061-2 R93357 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 1000 tablets
59762-1061-2 R93358 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 1000 tablets
59762-1061-2 R97310 2021 OCT 31 2.5 mg/0.025 mg Bottle containing 1000 tablets